$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| CLARIFICATION REGARDING PFIZER STATEMENT | 20 May 2014 |
| RULE 2.10 ANNOUNCEMENT | 20 May 2014 |
| RULE 2.10 ANNOUNCEMENT | 19 May 2014 |
| ASTRAZENECA BOARD REJECTS PFIZER?S FINAL PROPOSAL | 19 May 2014 |
| RULE 2.10 ANNOUNCEMENT | 16 May 2014 |
| ASTRAZENECA ONCOLOGY PIPELINE UPDATE AHEAD OF ASCO | 15 May 2014 |
| CONTINUING PROGRESS IN LATE STAGE PIPELINE | 15 May 2014 |
| RULE 2.10 ANNOUNCEMENT | 15 May 2014 |
| MEDIMMUNE ANNOUNCES IMMUNO-ONCOLOGY COLLABORATION | 14 May 2014 |
| RULE 2.10 ANNOUNCEMENT | 14 May 2014 |
| STATEMENT REGARDING PFIZER ANNOUNCEMENT | 13 May 2014 |
| RULE 2.10 ANNOUNCEMENT | 13 May 2014 |
| AZ PHASE III SAXA/DAPA RESULTS | 13 May 2014 |
| RULE 2.10 ANNOUNCEMENT | 12 May 2014 |
| AMGEN & AZ BRODALUMAB PHASE III RESULTS | 12 May 2014 |
| FORM 8 (OPD) PFIZER INC. | 12 May 2014 |
| FORM 8 (OPD) ASTRAZENECA PLC | 12 May 2014 |
| AZ ANNOUNCES RESULTS OF PHASE IIB STUDIES | 12 May 2014 |
| AZ TO PRESENT DATA AT ATS 2014 | 12 May 2014 |
| RULE 2.10 ANNOUNCEMENT | 09 May 2014 |
